The Intersection of Clinical Pharmacy, Microbial Resistance, and Public Health: Shaping Future Healthcare Policies

Abstract

Antimicrobial resistance (AMR) represents one of the most pressing global health challenges, resulting from the misuse and overuse of antibiotics in human medicine, agriculture, and environmental practices. This phenomenon threatens the efficacy of antibiotics, leading to increased mortality, longer hospital stays, and higher healthcare costs. This includes unprecedented role clinical pharmacists are playing for the war against AMR and their position on stewardship ASPs, educating patients and care providers, and formulating evidence-based policies. It goes on to discuss integrating the "One Health" approach by emphasizing connections between human, animal, and environmental health in attempting to check the rise in AMR; in this report, its economic and epidemiological effects, and call for greater collaboration and innovating new policy. The paper discusses critical interventions, including vaccination programs, stringent infection control measures, and enhanced surveillance systems. It then presents interdisciplinary research and technological advances as tools to drive solutions that are sustainable. This paper fosters a culture of collaboration through the expertise of clinical pharmacists and advocates for comprehensive and actionable strategies to address the issue of AMR while safeguarding global health.